Suvorexant Nitroso Impurity 4 - Request Quote
Suvorexant Nitroso Impurity 4
| SZ CAT No: | SZ-S052047 |
| CAS No | NA |
| Mol.F. | C6H13N3O |
| Mol.Wt. | 143.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Suvorexant Nitroso Impurity 4 is chemically (R)-7-Methyl-1-nitroso-1,4-diazepane. Suvorexant Nitroso Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Suvorexant Nitroso Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Suvorexant.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Suvorexant Nitroso Impurity 4
Purchase Suvorexant Nitroso Impurity 4
Suvorexant Nitroso Impurity 4 suppliers
Suvorexant Nitroso Impurity 4 manufacturers
Suvorexant Nitroso Impurity 4 price
Order Suvorexant Nitroso Impurity 4
Enquire Suvorexant Nitroso Impurity 4
Suvorexant Nitroso Impurity 4 cost
Suvorexant Nitroso Impurity 4 Supplier
Suvorexant Nitroso Impurity 4 Distributor
Suvorexant Nitroso Impurity 4 for Method Validation
Suvorexant Reference Standard
Suvorexant Nitroso Impurity 4 for ANDA Filing
Suvorexant Nitroso Impurity 4 for Forced Degradation Studies
Suvorexant Nitroso Impurity 4 Identification Standards
Suvorexant Nitroso Impurity 4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


